Hexagon
Biotech company using genomics and AI to discover novel small-molecule medicines from microbial genomes.
About
Hexagon Bio is a biopharmaceutical company that leverages a proprietary interdisciplinary platform combining machine learning, genomics, synthetic biology, and automation. They mine microbial genomes to discover and develop structurally diverse small-molecule therapeutics for oncology and infectious diseases.
Technology stack
detected 2026-06-15Est. monthly stack spend~$500/mo
Email
Google Workspace
Stack
jQuery
WordPress
SEO
Yoast SEO
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Hexagon do?
Hexagon Bio is a biopharmaceutical company that leverages a proprietary interdisciplinary platform combining machine learning, genomics, synthetic biology, and automation. They mine microbial genomes to discover and develop structurally diverse small-molecule therapeutics for oncology and infectious diseases.
How much funding has Hexagon raised?
Hexagon has raised a total of $61M in funding. The most recent round on record is Series A.
Where is Hexagon headquartered?
Hexagon is headquartered in Menlo Park, United States.
When was Hexagon founded?
Hexagon was founded in 2017.
What industry does Hexagon operate in?
Hexagon operates in AI, Biotech, Drug Discovery.
How many employees does Hexagon have?
Hexagon has approximately 67 people on record.